Kemppainen N - Search Results

1

Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease.

Kemppainen N, Laine M, Laakso MP, Kaasinen V, Någren K, Vahlberg T, Kurki T, Rinne JO. Kemppainen N, et al. Eur J Neurosci. 2003 Jul;18(1):149-54. doi: 10.1046/j.1460-9568.2003.02716.x. Eur J Neurosci. 2003. PMID: 12859348 Clinical Trial.

2

PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD.

Kemppainen N, Ruottinen H, Nâgren K, Rinne JO. Kemppainen N, et al. Neurology. 2000 Jul 25;55(2):205-9. doi: 10.1212/wnl.55.2.205. Neurology. 2000. PMID: 10908891

3

Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageing.

Kemppainen N, Marjamäki P, Röyttä M, Rinne JO. Kemppainen N, et al. J Neural Transm (Vienna). 2001;108(7):827-36. doi: 10.1007/s007020170032. J Neural Transm (Vienna). 2001. PMID: 11515748

4

Unbiased morphological measurements show no neuronal loss in the substantia nigra in Alzheimer's disease.

Kemppainen N, Röyttä M, Collan Y, Ma SY, Hinkka S, Rinne JO. Kemppainen N, et al. Acta Neuropathol. 2002 Jan;103(1):43-7. doi: 10.1007/s004010100425. Acta Neuropathol. 2002. PMID: 11837746

5

Age-related loss of extrastriatal dopamine D(2) -like receptors in women.

Kaasinen V, Kemppainen N, Någren K, Helenius H, Kurki T, Rinne JO. Kaasinen V, et al. Among authors: kemppainen n. J Neurochem. 2002 Jun;81(5):1005-10. doi: 10.1046/j.1471-4159.2002.00895.x. J Neurochem. 2002. PMID: 12065612 Free article. Clinical Trial.

6

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.

Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO. Kemppainen NM, et al. Neurology. 2006 Nov 14;67(9):1575-80. doi: 10.1212/01.wnl.0000240117.55680.0a. Epub 2006 Sep 13. Neurology. 2006. PMID: 16971697

7

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO. Kemppainen NM, et al. Neurology. 2007 May 8;68(19):1603-6. doi: 10.1212/01.wnl.0000260969.94695.56. Neurology. 2007. PMID: 17485647

8

Brain white matter expansion in human obesity and the recovering effect of dieting.

Haltia LT, Viljanen A, Parkkola R, Kemppainen N, Rinne JO, Nuutila P, Kaasinen V. Haltia LT, et al. Among authors: kemppainen n. J Clin Endocrinol Metab. 2007 Aug;92(8):3278-84. doi: 10.1210/jc.2006-2495. Epub 2007 May 29. J Clin Endocrinol Metab. 2007. PMID: 17536002

9

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease.

Kemppainen NM, Aalto S, Karrasch M, Någren K, Savisto N, Oikonen V, Viitanen M, Parkkola R, Rinne JO. Kemppainen NM, et al. Ann Neurol. 2008 Jan;63(1):112-8. doi: 10.1002/ana.21212. Ann Neurol. 2008. PMID: 18023012

10

Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication.

Remes AM, Laru L, Tuominen H, Aalto S, Kemppainen N, Mononen H, Någren K, Parkkola R, Rinne JO. Remes AM, et al. Among authors: kemppainen n. Arch Neurol. 2008 Apr;65(4):540-4. doi: 10.1001/archneur.65.4.540. Arch Neurol. 2008. PMID: 18413480

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters